| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0061 | 1 |